Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Br J Surg ; 111(1)2024 Jan 03.
Artículo en Inglés | MEDLINE | ID: mdl-38055889

RESUMEN

BACKGROUND: There is a clinical need for treatments that can slow or prevent the growth of an abdominal aortic aneurysm, not only to reduce the need for surgery, but to provide a means to treat those who cannot undergo surgery. METHODS: Analysis of the UK Aneurysm Growth Study (UKAGS) prospective cohort was conducted to test for an association between cardiometabolic medications and the growth of an abdominal aortic aneurysm above 30 mm in diameter, using linear mixed-effect models. RESULTS: A total of 3670 male participants with data available on abdominal aortic aneurysm growth, smoking status, co-morbidities, and medication history were included. The mean age at recruitment was 69.5 years, the median number of surveillance scans was 6, and the mean(s.e.) unadjusted abdominal aortic aneurysm growth rate was 1.75(0.03) mm/year. In a multivariate linear mixed-effect model, smoking (mean(s.e.) +0.305(0.07) mm/year, P = 0.00003) and antiplatelet use (mean(s.e.) +0.235(0.06) mm/year, P = 0.00018) were found to be associated with more rapid abdominal aortic aneurysm growth, whilst metformin was strongly associated with slower abdominal aortic aneurysm growth (mean(s.e.) -0.38(0.1) mm/year, P = 0.00019), as were angiotensin-converting enzyme inhibitors (mean(s.e.) -0.243(0.07) mm/year, P = 0.0004), angiotensin II receptor antagonists (mean(s.e.) -0.253(0.08) mm/year, P = 0.00255), and thiazides/related diuretics (mean(s.e.) -0.307(0.09) mm/year, P = 0.00078). CONCLUSION: The strong association of metformin with slower abdominal aortic aneurysm growth highlights the importance of the ongoing clinical trials assessing the effectiveness of metformin with regard to the prevention of abdominal aortic aneurysm growth and/or rupture. The association of angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, and diuretics with slower abdominal aortic aneurysm growth points to the possibility that optimization of cardiovascular risk management as part of abdominal aortic aneurysm surveillance may have the secondary benefit of also reducing abdominal aortic aneurysm growth rates.


Asunto(s)
Aneurisma de la Aorta Abdominal , Metformina , Humanos , Masculino , Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico , Metformina/uso terapéutico , Estudios Prospectivos , Aneurisma de la Aorta Abdominal/tratamiento farmacológico , Diuréticos/uso terapéutico , Antagonistas de Receptores de Angiotensina/uso terapéutico , Reino Unido/epidemiología
2.
Genetica ; 147(3-4): 249-258, 2019 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31392547

RESUMEN

Throughout the world, there is a male-bias in the sex ratio at birth (SRB). It is not known whether this phenomenon has a genetic basis, though there is tentative evidence from genealogical and genomic studies that it may have. It has been proposed that the higher rate of male childhood mortality in humans is linked to the male-bias in SRB through parental investment, but this may only apply to facultative not genetic sex ratio adjustment. In previous population genetic models, elevated mortality in one sex (prior to breeding) has been shown not to affect the SRB, but these models did not consider the role of replacement births (i.e. births that only occur because a sibling died prematurely). In a set of population genetic modelling simulations, in which sex ratio is controlled by an autosomal gene expressed in the male line, this study shows that when there is replacement of dead offspring, this leads to a sustained bias in the SRB in the direction of the sex suffering the highest mortality. In the example of higher male mortality, this occurs, because replacement offspring are disproportionately drawn from fathers who were genetically predisposed to have initially had sons (because sons were more likely to die prematurely), and more likely to pass on male-biasing alleles to replacement offspring. To test the empirical basis for replacement births, an analysis of birth data from the Demographic and Health Survey program was conducted, which shows that parents do indeed tend to replace children who die prematurely.


Asunto(s)
Razón de Masculinidad , Niño , Mortalidad del Niño , Demografía , Composición Familiar , Femenino , Genotipo , Humanos , Lactante , Mortalidad Infantil , Masculino
3.
medRxiv ; 2024 Sep 14.
Artículo en Inglés | MEDLINE | ID: mdl-39314961

RESUMEN

Introduction: Lipoprotein(a) (Lp(a)) is a circulating apolipoprotein B (ApoB) containing particle that has been observationally linked to atherosclerotic cardiovascular disease and is the target of emerging therapeutics. Recent work has highlighted the role of circulating lipoproteins in abdominal aortic aneurysm (AAA). We sought to triangulate human observational and genetic evidence to evaluate the role of Lp(a) in AAA. Methods: We tested the association between circulating levels of Lp(a) and clinically diagnosed abdominal aortic aneurysms while controlling for traditional AAA risk factors and levels of ApoB using logistic regression among 795 individuals with and 374,772 individuals without AAA in the UK Biobank (UKB). Multivariable Mendelian randomization (MVMR) was used to test for putatively causal associations between Lp(a) and AAA controlling for ApoB. Genetic instruments for Lp(a) and ApoB were created from genome-wide association studies (GWAS) of Lp(a) and ApoB comprising 335,796 and 418,505 UKB participants, respectively. The instruments were tested for association with AAA using data from a GWAS of 39,221 individuals with and 1,086,107 without AAA. Results: Elevated Lp(a) levels were observationally associated with an increased risk of AAA (OR 1.04 per 10 nmol/L Lp(a); 95%CI 1.02-1.05; P<0.01). Clinically elevated Lp(a) levels (>150nmol/L) were likewise associated with an increased risk of AAA (OR 1.47; 95% CI 1.15-1.88; P < 0.01) when compared to individuals with Lp(a) levels <150nmol/L. MVMR confirmed a significant, ApoB-independent association between increased Lp(a) and increased risk of AAA (OR 1.13 per SD increase in Lp(a); 95%CI 1.02-1.24; P<0.02). Conclusion: Both observational and genetic analyses support an association between increased Lp(a) and AAA risk that is independent of ApoB. These findings suggest that Lp(a) may be a therapeutic target for AAA and drive the inclusion of AAA as an outcome in clinical trials of Lp(a) antagonists.

4.
Nat Genet ; 55(11): 1831-1842, 2023 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-37845353

RESUMEN

Abdominal aortic aneurysm (AAA) is a common disease with substantial heritability. In this study, we performed a genome-wide association meta-analysis from 14 discovery cohorts and uncovered 141 independent associations, including 97 previously unreported loci. A polygenic risk score derived from meta-analysis explained AAA risk beyond clinical risk factors. Genes at AAA risk loci indicate involvement of lipid metabolism, vascular development and remodeling, extracellular matrix dysregulation and inflammation as key mechanisms in AAA pathogenesis. These genes also indicate overlap between the development of AAA and other monogenic aortopathies, particularly via transforming growth factor ß signaling. Motivated by the strong evidence for the role of lipid metabolism in AAA, we used Mendelian randomization to establish the central role of nonhigh-density lipoprotein cholesterol in AAA and identified the opportunity for repurposing of proprotein convertase, subtilisin/kexin-type 9 (PCSK9) inhibitors. This was supported by a study demonstrating that PCSK9 loss of function prevented the development of AAA in a preclinical mouse model.


Asunto(s)
Aneurisma de la Aorta Abdominal , Estudio de Asociación del Genoma Completo , Humanos , Animales , Ratones , Proproteína Convertasa 9/genética , Proproteína Convertasa 9/metabolismo , Subtilisina , Proproteína Convertasas , Aneurisma de la Aorta Abdominal/genética
5.
Curr Biol ; 30(20): R1261-R1263, 2020 10 19.
Artículo en Inglés | MEDLINE | ID: mdl-33080196

RESUMEN

At face value, questions about the sex ratio have always seemed to have straightforward answers, which on closer inspection turn out to be fiendishly complex. The familial distribution of male and female births is no exception.


Asunto(s)
Reproducción , Razón de Masculinidad , Femenino , Humanos , Masculino
6.
J Am Heart Assoc ; 8(20): e013743, 2019 10 15.
Artículo en Inglés | MEDLINE | ID: mdl-31595818

RESUMEN

Background It is recognized that factors beyond aortic size are important in predicting outcome in abdominal aortic aneurysm (AAA) disease. AAA is characterized by the breakdown of elastin within the aortic tunica media, leading to aortic dilatation and rupture. The aim of this study was to investigate the association of plasma desmosine (pDES), an elastin-specific degradation product, with disease severity and clinical outcome in patients with AAA. Methods and Results We measured pDES and serum biomarker concentrations in 507 patients with AAAs (94% men; mean age, 72.4±6.1 years; mean AAA diameter, 48±8 mm) and 162 control subjects (100% men; mean age, 71.5±4.4 years) from 2 observational cohort studies. In the longitudinal cohort study (n=239), we explored the incremental prognostic value of pDES on AAA events. pDES was higher in patients with AAA compared with control subjects (mean±SD: 0.46±0.22 versus 0.33±0.16 ng/mL; P<0.001) and had the strongest correlation with AAA diameter (r=0.39; P<0.0001) of any serum biomarker. After adjustment for baseline AAA diameter, pDES was associated with an AAA event (hazard ratio, 2.03 per SD increase [95% CI, 1.02-4.02]; P=0.044). In addition to AAA diameter, pDES provided incremental improvement in risk stratification (continuous net reclassification improvement, 34.4% [95% CI, -10.8% to 57.5%; P=0.09]; integrated discrimination improvement, 0.04 [95% CI, 0.00-0.15; P=0.050]). Conclusions pDES concentrations predict disease severity and clinical outcomes in patients with AAA. Clinical Trial Registration http://www.isrctn.com. Unique identifier: ISRCTN76413758.


Asunto(s)
Aorta Abdominal/diagnóstico por imagen , Aneurisma de la Aorta Abdominal/sangre , Desmosina/sangre , Anciano , Aneurisma de la Aorta Abdominal/diagnóstico , Aneurisma de la Aorta Abdominal/epidemiología , Biomarcadores/sangre , Cateterismo Cardíaco , Femenino , Estudios de Seguimiento , Humanos , Incidencia , Masculino , Pronóstico , Estudios Prospectivos , Tasa de Supervivencia/tendencias , Ultrasonografía , Reino Unido/epidemiología
7.
J Epidemiol Community Health ; 71(3): 269-274, 2017 03.
Artículo en Inglés | MEDLINE | ID: mdl-27777265

RESUMEN

BACKGROUND: The Indian sex ratio has become highly male-biased in recent decades. This may be attributed to prenatal sex selection (PSS) and excess female infant mortality. However, the question of whether these factors are related has not been adequately studied. Here we examine whether increased use of PSS may offset excess female infant mortality, by reducing the number of 'unwanted' daughters being born. METHODS: We analyse the National Family Health Survey (NHFS) data sets for India, which contain nationally representative samples of birth histories for women aged 15-49, interviewed in 1992-1993, 1998-1999 and 2005-2006. We test for missing female births at the second and third birth order, by analysis of the frequencies of sibling sex combinations, and examine the mortality differential between male and female infants, controlling for household wealth and sex(es) of older siblings. RESULTS: PSS was used most in wealthier households at the second and third birth order, when the firstborn, or firstborn and second-born, siblings were female. Having preceding female siblings was a significant risk factor for female infant mortality, but was not correlated with household wealth. CONCLUSIONS: PSS and female infant mortality increase with the presence of older female siblings, yet we find no evidence that increasing use of PSS prevents female infant mortality, because PSS and the proportion of female infant mortality attributable to having older sisters increased over the study period. Increased pressure on higher birth order females caused by the trend towards smaller family sizes may explain this.


Asunto(s)
Mortalidad Infantil , Núcleo Familiar , Preselección del Sexo , Adolescente , Adulto , Orden de Nacimiento , Femenino , Humanos , India , Lactante , Recién Nacido , Persona de Mediana Edad , Factores de Riesgo , Razón de Masculinidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA